Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Psychiatric comorbidity is associated with disability progression in multiple sclerosis.

McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Neurology. 2018 Apr 10;90(15):e1316-e1323. doi: 10.1212/WNL.0000000000005302. Epub 2018 Mar 9.

PMID:
29523642
2.

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.

Zhang T, Kingwell E, Zhu F, Petkau J, Kastrukoff LF, Marrie RA, Tremlett H, Evans C.

BMJ Open. 2017 Sep 29;7(9):e018612. doi: 10.1136/bmjopen-2017-018612.

3.

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.

McKay KA, Tremlett H, Zhu F, Kastrukoff L, Marrie RA, Kingwell E.

Eur J Neurol. 2016 Jun;23(6):1093-100. doi: 10.1111/ene.12990. Epub 2016 Mar 15.

4.

A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice.

Kastrukoff LF, Lau AS, Takei F, Carbone FR, Scalzo AA.

Immunol Cell Biol. 2015 Nov;93(10):877-84. doi: 10.1038/icb.2015.54. Epub 2015 May 14.

PMID:
25971711
5.

The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).

Kastrukoff LF, Lau AS, Thomas EE.

Herpesviridae. 2012 Mar 26;3:4. doi: 10.1186/2042-4280-3-4.

6.

Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice.

Kastrukoff LF, Lau AS, Takei F, Smyth MJ, Jones CM, Clarke SR, Carbone FR.

Virology. 2010 May 10;400(2):248-58. doi: 10.1016/j.virol.2010.02.013. Epub 2010 Mar 2.

7.

Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity.

Kastrukoff LF, Lau A, Wee R, Zecchini D, White R, Paty DW.

J Neuroimmunol. 2003 Dec;145(1-2):103-14.

PMID:
14644036
8.
9.

Genetic susceptibility to MS: a second stage analysis in Canadian MS families.

Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J, Paty DW, Hashimoto S, Devonshire V, Hooge J, Kastrukoff L, Oger J, Metz L, Warren S, Hader W, Power C, Auty A, Nath A, Nelson R, Freedman M, Brunet D, Paulseth JE, Rice G, O'Connor P, Duquette P, Lapierre Y, Francis G, Bouchard JP, Murray TJ, Bhan V, Maxner C, Pryse-Phillips W, Stefanelli M, Sadovnick AD, Risch N, Ebers GC.

Neurogenetics. 2001 Jul;3(3):145-51.

PMID:
11523565
10.

Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.

Al-Fahim A, Cabre P, Kastrukoff L, Dorovini-Zis K, Oger J.

Cell Immunol. 1999 Nov 25;198(1):1-10.

PMID:
10612646
11.

Axonal cytoskeleton changes in experimental optic neuritis.

Zhu B, Moore GR, Zwimpfer TJ, Kastrukoff LF, Dyer JK, Steeves JD, Paty DW, Cynader MS.

Brain Res. 1999 Apr 10;824(2):204-17.

PMID:
10196450
12.

Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.

Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW.

Neurology. 1999 Jan 15;52(2):351-9.

PMID:
9932956
13.

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

Kastrukoff LF, Morgan NG, Zecchini D, White R, Petkau AJ, Satoh J, Paty DW.

J Neuroimmunol. 1998 Jun 15;86(2):123-33.

PMID:
9663557
15.

Depression and multiple sclerosis.

Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW.

Neurology. 1996 Mar;46(3):628-32.

PMID:
8618657
16.

Pregnancy and multiple sclerosis. A prospective study.

Sadovnick AD, Eisen K, Hashimoto SA, Farquhar R, Yee IM, Hooge J, Kastrukoff L, Oger JJ, Paty DW.

Arch Neurol. 1994 Nov;51(11):1120-4.

PMID:
7980107
17.

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.

Paty DW, Li DK, Oger JJ, Kastrukoff L, Koopmans R, Tanton E, Zhao GJ.

Ann Neurol. 1994;36 Suppl:S95-6.

PMID:
8017896
18.

The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis.

Koopmans RA, Li DK, Redekop WK, Zhao GJ, Palmer MR, Kastrukoff LF, Paty DW.

J Neuroimaging. 1993 Jul;3(3):163-8.

PMID:
10146223
19.
20.

Herpes simplex virus type I (HSV I)-induced multifocal central nervous system (CNS) demyelination in mice.

Kastrukoff LF, Lau AS, Leung GY, Walker DG, Thomas EE.

J Neuropathol Exp Neurol. 1992 Jul;51(4):432-9. Erratum in: J Neuropathol Exp Neurol 1992 Nov;51(6):658. Walker D [corrected to Walker DG].

PMID:
1619442
21.

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation.

Kastrukoff LF, Oger JJ, Tourtellotte WW, Sacks SL, Berkowitz J, Paty DW.

Neurology. 1991 Dec;41(12):1936-41.

PMID:
1745353
22.

Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice.

Thomas EE, Lau AS, Kim SU, Osborne D, Kastrukoff LF.

J Gen Virol. 1991 Sep;72 ( Pt 9):2051-7.

PMID:
1654369
24.

Lymphokine-activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis.

Satoh J, Kim SU, Kastrukoff LF.

J Neuroimmunol. 1991 May;32(2):111-22.

PMID:
2013616
26.

Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes.

Satoh J, Kastrukoff LF, Kim SU.

J Neuropathol Exp Neurol. 1991 May;50(3):215-26.

PMID:
1673709
27.

Cytolysis of oligodendrocytes is mediated by killer (K) cells but not by natural killer (NK) cells.

Satoh J, Kim SU, Kastrukoff LF.

J Neuroimmunol. 1991 Mar;31(3):199-210.

PMID:
1995651
28.

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.

Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, Koopmans RA, Petkau AJ, Berkowitz J, Paty DW.

Neurology. 1990 Mar;40(3 Pt 1):479-86.

PMID:
2179764
29.

Absence of natural killer (NK) cell activity against oligodendrocytes in multiple sclerosis.

Satoh J, Kim SU, Kastrukoff LF.

J Neuroimmunol. 1990 Jan;26(1):75-80.

PMID:
2294144
30.

Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months.

Koopmans RA, Li DK, Oger JJ, Kastrukoff LF, Jardine C, Costley L, Hall S, Grochowski EW, Paty DW.

Ann Neurol. 1989 Aug;26(2):248-56.

PMID:
2774512
31.

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients.

Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW.

Ann Neurol. 1989 Jan;25(1):43-9.

PMID:
2913928
32.

Biologic versus clinical MS.

Paty DW, Eisen KA, Oger JJ, Purves SJ, Kastrukoff LF, Low M, Hashimoto SA, Brandjes V, Hooge JJ, Robertson W, et al.

Neurology. 1989 Jan;39(1):151-3. No abstract available.

PMID:
2642612
33.

Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI.

Oger J, Kastrukoff LF, Li DK, Paty DW.

Neurology. 1988 Nov;38(11):1739-44.

PMID:
3185908
34.

Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon.

Kastrukoff LF, Morgan NG, Aziz TM, Zecchini D, Berkowitz J, Paty DW.

J Neuroimmunol. 1988 Nov;20(1):15-23.

PMID:
3183034
35.

Multiple sclerosis: a serial study using MRI in relapsing patients.

Isaac C, Li DK, Genton M, Jardine C, Grochowski E, Palmer M, Kastrukoff LF, Oger J, Paty DW.

Neurology. 1988 Oct;38(10):1511-5.

PMID:
3419593
36.

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V, et al.

Neurology. 1988 Feb;38(2):180-5.

PMID:
3340277
37.

Herpes simplex virus type 1 induced multifocal demyelination of the central nervous system in mice.

Kastrukoff LF, Lau AS, Kim SU.

Ann N Y Acad Sci. 1988;540:654-6. No abstract available.

PMID:
2849908
38.

Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1.

Kastrukoff LF, Lau AS, Kim SU.

Ann Neurol. 1987 Jul;22(1):52-9.

PMID:
2820296
39.

A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.

Bozek CB, Kastrukoff LF, Wright JM, Perry TL, Larsen TA.

J Neurol. 1987 Jan;234(1):36-9.

PMID:
3546605
41.
42.
44.
45.

Suppressor T cells in MS: do changes in numbers vary with clinical activity?

Paty DW, Kastrukoff LF.

Ann N Y Acad Sci. 1984;436:266-70. No abstract available.

PMID:
6241818
46.

A longitudinal study of T cell subset surface antigen expression in multiple sclerosis.

Paty DW, Kastrukoff LF.

Prog Clin Biol Res. 1984;146:119-24. No abstract available.

PMID:
6232622
47.
48.

Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1.

Kastrukoff L, Hamada T, Schumacher U, Long C, Doherty PC, Koprowski H.

J Neuroimmunol. 1982 Jun;2(3-4):295-305.

PMID:
6282930
49.

Isolation of virus from brain after immunosuppression of mice with latent herpes simplex.

Kastrukoff L, Long C, Doherty PC, Wroblewska Z, Koprowski H.

Nature. 1981 Jun 4;291(5814):432-3. No abstract available.

PMID:
6264308
50.

Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis.

Santoli D, Hall W, Kastrukoff L, Lisak RP, Perussia B, Trinchieri G, Koprowski H.

J Immunol. 1981 Apr;126(4):1274-8.

PMID:
6162885

Supplemental Content

Loading ...
Support Center